Kirurgian vastuualue

Julkaisut 2018 (alustava)
Publications 2018 (preliminary)

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Ahlgren G et al. Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised. Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.
2 Auvinen A et al. Uusi eturauhassyövän seulontatutkimus pyrkii parantamaan hyötyjen ja haittojen suhdetta.
3 Booth N et al. Costs of screening for prostate cancer: Evidence from the Finnish Randomised Study of Screening for Prostate Cancer after 20-year follow-up using register data.
4 Bosiers MJ et al. Incidence and prognostic factors related to major adverse cerebrovascular events in patients with complex aortic diseases treated by the chimney technique.
5 Dadaey T et al. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
6 Ebbinge M et al. Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer.
7 Fitzgerald LM et al. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
8 Gao P et al. Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.
9 Harju J et al. Comparison of non-invasive blood pressure monitoring using modified arterial applanation tonometry with intra-arterial measurement.
10 Högnäs G et al. Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology: Comparison of Matched Fresh Frozen, FFPE, and PFPE Tissues.
11 Jeyhani V et al. A novel technique for analysis of postural information with wearable devices.
12 Jolma P et al. Oral Dipyridamole-Associated Circulatory Collapse.
13 Jämsä P et al. Moderate to severe renal insufficiency is associated with high mortality following hip and knee replacement.
14 Jämsä P et al. Moderate to Severe Renal Insufficiency Is Associated With High Mortality After Hip and Knee Replacement.
15 Jämsä P et al. Chronic Kidney Diseases Among Patients Undergoing Elective Arthroplasty: Risk Groups and the Value of Serum Creatinine.
16 Järvelä KM et al. Hyperglycemic Episodes Are Associated With Postoperative Infections After Cardiac Surgery.
17 Kaapu KJ et al. Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men.
18 Kaikkonen E et al. ANO7 is associated with aggressive prostate cancer.
19 Kallio H et al. Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases.
20 Karjalainen M et al. The characterization of surgical smoke from various tissues and its implications for occupational safety.
21 Khan N et al. Extended Serum Lipid Profile Predicting Long-Term Survival in Patients Treated for Abdominal Aortic Aneurysms.
22 Knaapila J et al. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
23 Knoll T et al. Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of Urology.
24 Koivusalo L et al. Digital image analysis of the tissue surface areas of site-designated and bilaterally pooled prostate biopsies.
25 Kontunen A et al. Tissue Identification in a Porcine Model by Differential Ion Mobility Spectrometry Analysis of Surgical Smoke.
26 Kukko V et al. Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort.
27 Lappalainen J et al. Suppressed heat shock protein response in the kidney of exercise-trained diabetic rats.
28 Latonen L et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression.
29 Lehto U et al. Experiences and psychological distress of spouses of prostate cancer patients at time of diagnosis and primary treatment.
30 Matejcic M et al. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.
31 Murto MO et al. Breast cancer extent and survival among diabetic women in a Finnish nationwide cohort study.
32 Murtola T et al. Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.
33 Murtola T et al. Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
34 Murtola TJ et al. Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial.
35 Mäkelä VJ et al. Bladder Cancer Survival of Men Receiving 5a-Reductase Inhibitors.
36 Niemi RJ et al. FAIMS analysis of urine gaseous headspace is capable of differentiating ovarian cancer.
37 Oksala N, Roine A. Toimenpiteenaikainen kudostunnistus.
38 Ollikainen J et al. The Finnish Prehospital Stroke Scale Detects Thrombectomy and Thrombolysis Candidates-A Propensity Score-Matched Study.
39 Pajamäki N et al. Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer.
40 Peltokangas J et al. The effect of percutaneous transluminal angioplasty of superficial femoral artery on pulse wave features.
41 Peltokangas M et al. Parameters Extracted From Arterial Pulse Waves as Markers of Atherosclerotic Changes: Performance and Repeatability.
42 Peltokangas M et al. Areas under peripheral pulse waves: a potential marker of atherosclerotic changes.
43 Pietilä I et al. Seeking certainty through narrative closure: men's stories of prostate cancer treatments in a state of liminality.
44 Pöyhönen A et al. Severity and bother of lower urinary tract symptoms among men aged 30-80 years: Tampere Ageing Male Urological Study (TAMUS).
45 Rantaniemi L et al. Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy.
46 Rinne P et al. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
47 Rinne P et al. Pro-opiomelanocortin and its Processing Enzymes Associate with Plaque Stability in Human Atherosclerosis - Tampere Vascular Study.
48 Saarinen I et al. Systematic review of hospital-wide complication registries.
49 Salenius J-P et al. Subclavian steal -oireyhtymän diagnostiikka.
50 Salminen A et al. 11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial).
51 Salminen A et al. C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial).
52 Salminen A et al. Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study.
53 Saviauk T et al. Electronic Nose in the Detection of Wound Infection Bacteria from Bacterial Cultures: A Proof-of-Principle Study.
54 Scali ST et al. Identification of optimal device combinations for the chimney endovascular aneurysm repair technique within the PERICLES registry.
55 Schumacher FR et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
56 Seibert TM et al. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
57 Shore ND et al. Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials.
58 Shutze W et al. The incidence and effect of noncylindrical neck morphology on outcomes after endovascular aortic aneurysm repair in the Global Registry for Endovascular Aortic Treatment.
59 Siltari A et al. Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort.
60 Sipeky C et al. Synergistic Interaction of of HOXB13 and CIP2A predisposes to aggressive prostate cancer.
61 Smith M et al. Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
62 Suominen V, Vikatmaa P. Verisuonivammat.
63 Suominen V, Vikatmaa P. Verisuonivammojen hoito.
64 Suominen V, Vikatmaa P. Kaulan verisuonivammat.
65 Suominen V, Vikatmaa P. Kaulan verisuonivammojen hoito.
66 Suominen V, Vikatmaa P. Rintakehän ja vatsan alueen suurten suonten vammat.
67 Suominen V, Vikatmaa P. Raajojen verisuonivammat.
68 Suominen V, Vikatmaa P. Raajojen verisuonivammojen hoito .
69 Taipale T et al. Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study.
70 Tammela T. Johdanto eturauhasen sairauksiin.
71 Tammela T. Eturauhassyövän diagnostiikka.
72 Tammela T. Bakteerien aiheuttamat eturauhastulehdukset (tyypit 1 ja 2).
73 Tammela T. Krooninen eturauhastulehdus ilman bakreerilöydöstä (krooninen lantion kiputila).
74 Tammela T. Yleistä erektiohäiriöistä.
75 Tammela T. Erektiohäiriöiden diagnostiikka.
76 Tammela T. Erektiohäiriöiden konservatiivinen hoito.
77 Tammela T. Erektiohäiriöiden kirurginen hoito.
78 Tammela T. Eturauhasen hyvänlaatuisen liikakasvun diagnostiikka.
79 Tammela T. Eturauhasen hyvänlaatuisen liikakasvun hoito.
80 Tammela T. Eturauhassyövän hoito.
81 Tammela T. Eturauhastulehduksen diagnostiikka.
82 Tolonen TT et al. Extraprostatic extension (pT3a) in prostate biopsy is an under-recognized feature indicating high risk disease.
83 Uurto I et al. Glomustuumori.
84 Uurto I et al. Glomustuumorin diagnostiikka.
85 Uurto I et al. Glomustuumorin hoito ja hoitotulokset.
86 Vakhitov D et al. Bacterial signatures in thrombus aspirates of patients with lower limb arterial and venous thrombosis.
87 Venermo M, Suominen V. Vatsa-aortan aneurysman diagnostiikka.
88 Venermo M, Suominen V. Vatsa-aortan aneurysman seuranta ja hoidon ajoitus.
89 Venäläinen MK et al. Altered Polyamine Profiles in Colorectal Cancer.
90 Vikatmaa P et al. Kaulavaltimoahtauma ja aivoinfarkti.
91 Vikatmaa P et al. Kaulavaltimoahtauman diagnostiikka.
92 Vikatmaa P et al. Kaulavaltimoahtauman hoidon suunnittelu.
93 Vikatmaa P et al. Kaulavaltimoahtauman hoito.
94 Virtanen J et al. In vitro detection of common rhinosinusitis bacteria by the eNose utilising differential mobility spectrometry.
95 Wahlström M et al. Resilience through interpretive practice - A study of robotic surgery.
Julkaisutietokanta 31.12.2019 Publications Data Base 31.12.2019